Eli Lilly, the maker of Mounjaro and Zepbound, is urging the court to impose stricter diagnostic proof requirements in the ongoing GLP-1 gastroparesis litigation
Heart Rate Monitoring Dose-dependent increases in heart rate were observed and monitored during research
Unlike older treatments, tirzepatide activates both receptors, providing enhanced benefits: reduced appetite, prolonged feelings of fullness, and improved insulin sensitivity
The results vary depending on skin type, genetics, and overall health
This subcutaneous injection, when combined with a reduced-calorie diet and increased physical activity, can support weight loss of up to two pounds per week